KING OF PRUSSIA, Pa. & LONDON--(BUSINESS WIRE)--DrugDev will present an educational webinar, “Good Measure: Driving Site Performance with Metrics-Based Communication” on April 2, 2015 featuring Beth Harper, President of Clinical Performance Partners, Inc. and DrugDev Director of Trial Site Experience Bryan Farrow. The complimentary webinar featuring an interactive and evidence-based discussion will provide actionable steps to improve your site performance.
Webinar: Good Measure: Driving Site Performance with Metrics-Based
Communication
Speakers: Beth Harper, President of Clinical
Performance Partners, Inc. and Bryan Farrow, Director, Trial Site
Experience, DrugDev
Date: April 2, 2015
Time: 10:00-11:00am EDT
CLICK
TO REGISTER
This webinar is complimentary
At the conclusion of the webinar and interactive Q&A attendees should be able to:
- Explain why metrics are so powerful, and identify which ones matter most
- Develop a site performance report template
- Recognize and reinforce the behaviors of top performing sites
- Energize lagging sites through transparent reporting of their performance
- Carry out a root cause analysis of site performance issues
- Lead a productive, supportive and fact based discussion with sites to maximize their performance
About the Speakers
Beth Harper is the President of Clinical Performance Partners, Inc., a clinical research consulting firm specializing in enrollment and site performance management and facilitating productive sponsor-site relationships. Beth leverages her 30 years of site, SMO, CRO, Pharma, Consulting, Training and Service Provider experiences, both domestically and internationally, to identify solutions for optimizing the clinical trials process.
Bryan Farrow is the Director of Trial Site Experience for the TrialNetworks study platform by DrugDev. Bryan is responsible for creating content that engages and educates study members spread across the globe, pioneered site-specific "report cards," and incorporates trial site feedback into network enhancements.
About DrugDev
DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com.
